BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31109948)

  • 1. Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA) Requires Death Receptor Fas, in Addition to LFA-1, To Trigger Cell Death in T Lymphocytes.
    Vega BA; Schober LT; Kim T; Belinka BA; Kachlany SC
    Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31109948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LFA-1-targeting Leukotoxin (LtxA; Leukothera®) causes lymphoma tumor regression in a humanized mouse model and requires caspase-8 and Fas to kill malignant lymphocytes.
    DiFranco KM; Johnson-Farley N; Bertino JR; Elson D; Vega BA; Belinka BA; Kachlany SC
    Leuk Res; 2015 Jun; 39(6):649-56. PubMed ID: 25850729
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Vega BA; Belinka BA; Kachlany SC
    Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31454891
    [No Abstract]   [Full Text] [Related]  

  • 4. Aggregatibacter actinomycetemcomitans leukotoxin (LtxA; Leukothera) induces cofilin dephosphorylation and actin depolymerization during killing of malignant monocytes.
    Kaur M; Kachlany SC
    Microbiology (Reading); 2014 Nov; 160(Pt 11):2443-2452. PubMed ID: 25169107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukotoxin (LtxA/Leukothera) induces ATP expulsion via pannexin-1 channels and subsequent cell death in malignant lymphocytes.
    Prince DJ; Patel D; Kachlany SC
    Sci Rep; 2021 Sep; 11(1):18086. PubMed ID: 34508147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukotoxin (Leukothera®) targets active leukocyte function antigen-1 (LFA-1) protein and triggers a lysosomal mediated cell death pathway.
    DiFranco KM; Gupta A; Galusha LE; Perez J; Nguyen TK; Fineza CD; Kachlany SC
    J Biol Chem; 2012 May; 287(21):17618-17627. PubMed ID: 22467872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human CD18 is the functional receptor for Aggregatibacter actinomycetemcomitans leukotoxin.
    Dileepan T; Kachlany SC; Balashova NV; Patel J; Maheswaran SK
    Infect Immun; 2007 Oct; 75(10):4851-6. PubMed ID: 17635865
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Lally ET; Boesze-Battaglia K; Dhingra A; Gomez NM; Lora J; Mitchell CH; Giannakakis A; Fahim SA; Benz R; Balashova N
    Pathogens; 2020 Jan; 9(2):. PubMed ID: 31973183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggregatibacter actinomycetemcomitans leukotoxin causes activation of lymphocyte function-associated antigen 1.
    Nygren P; Balashova N; Brown AC; Kieba I; Dhingra A; Boesze-Battaglia K; Lally ET
    Cell Microbiol; 2019 Mar; 21(3):e12967. PubMed ID: 30329215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialic acid residues are essential for cell lysis mediated by leukotoxin from Aggregatibacter actinomycetemcomitans.
    Munksgaard PS; Skals M; Reinholdt J; Poulsen K; Jensen MR; Yang C; Leipziger J; Vorup-Jensen T; Praetorius HA
    Infect Immun; 2014 Jun; 82(6):2219-28. PubMed ID: 24643533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-Based Peptides for Inhibition of Leukotoxin Activity.
    Krueger E; Hayes S; Chang EH; Yutuc S; Brown AC
    ACS Infect Dis; 2018 Jul; 4(7):1073-1081. PubMed ID: 29742342
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Nice JB; Balashova NV; Kachlany SC; Koufos E; Krueger E; Lally ET; Brown AC
    Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30322160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gangliosides block Aggregatibacter Actinomycetemcomitans leukotoxin (LtxA)-mediated hemolysis.
    Forman MS; Nishikubo JB; Han RK; Le A; Balashova NV; Kachlany SC
    Toxins (Basel); 2010 Dec; 2(12):2824-36. PubMed ID: 22069577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.
    Krueger E; Brown AC
    Mol Oral Microbiol; 2020 Jun; 35(3):85-105. PubMed ID: 32061022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggregatibacter actinomycetemcomitans leukotoxin induces cytosol acidification in LFA-1 expressing immune cells.
    Balashova N; Dhingra A; Boesze-Battaglia K; Lally ET
    Mol Oral Microbiol; 2016 Feb; 31(1):106-14. PubMed ID: 26361372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane localization of the Repeats-in-Toxin (RTX) Leukotoxin (LtxA) produced by Aggregatibacter actinomycetemcomitans.
    Brown AC; Boesze-Battaglia K; Balashova NV; Mas Gómez N; Speicher K; Tang HY; Duszyk ME; Lally ET
    PLoS One; 2018; 13(10):e0205871. PubMed ID: 30335797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monodisperse and LPS-free Aggregatibacter actinomycetemcomitans leukotoxin: interactions with human β2 integrins and erythrocytes.
    Reinholdt J; Poulsen K; Brinkmann CR; Hoffmann SV; Stapulionis R; Enghild JJ; Jensen UB; Boesen T; Vorup-Jensen T
    Biochim Biophys Acta; 2013 Feb; 1834(2):546-58. PubMed ID: 23234758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cells.
    Kachlany SC; Schwartz AB; Balashova NV; Hioe CE; Tuen M; Le A; Kaur M; Mei Y; Rao J
    Leuk Res; 2010 Jun; 34(6):777-85. PubMed ID: 19747730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and targeting of lymphocyte function-associated antigen 1 (LFA-1) on white blood cells for treatment of allergic asthma.
    Gupta A; Espinosa V; Galusha LE; Rahimian V; Miro KL; Rivera-Medina A; Kasinathan C; Capitle E; Aguila HA; Kachlany SC
    J Leukoc Biol; 2015 Mar; 97(3):439-46. PubMed ID: 25341726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggregatibacter actinomycetemcomitans leukotoxin utilizes a cholesterol recognition/amino acid consensus site for membrane association.
    Brown AC; Balashova NV; Epand RM; Epand RF; Bragin A; Kachlany SC; Walters MJ; Du Y; Boesze-Battaglia K; Lally ET
    J Biol Chem; 2013 Aug; 288(32):23607-21. PubMed ID: 23792963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.